MedPath

ORALIA Trial Medical Treatment vs Anoperineal Physiotherapy for Adult Anal Incontinence.

Not Applicable
Terminated
Conditions
Anal Incontinence
Interventions
Behavioral: Standard medical treatment
Behavioral: standard medical treatment + anoperineal physiotherapy.
Registration Number
NCT00387439
Lead Sponsor
Hospices Civils de Lyon
Brief Summary

The purpose of this study is to evaluate the impact of anoperineal physiotherapy in adjunction to standard medical treatment on symptoms and quality of life of adults with anal incontinence, in comparison with standard treatment alone.

A total of 443 patients will be randomized to 2 groups: standard care (medical treatment) alone or standard care associated with anoperineal physiotherapy. Outcome measures include the patient own view of the effectiveness of the treatment, the continence score, quality of life and psychological status. These outcomes are measured at the end of the 4 months treatment period.

Following this period, the non responders to standard medical treatment will be proposed to undergo a course of anoperineal physiotherapy and the non responders to anoperineal physiotherapy will be treated by transcutaneous electrical nerve stimulation (TENS). The outcomes will be measured at the end of the 4 months new treatment and again after 4 months follow-up.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
173
Inclusion Criteria
  • Age 18 to 75
  • Anal incontinence for more than six months.
  • Signed informed consent
  • Jorge and Wexner's anal incontinence score > or egal 5
Exclusion Criteria
  • Previous course of anoperineal physiotherapy within the past 6 months
  • Anorectal or perineal surgery within the past 6 months.
  • Indication for anoperineal surgery
  • Vaginal delivery within the past 6 months
  • Pregnancy
  • Major neurological disease,
  • Significant cognitive impairment, dementia or institutionalised.
  • Active inflammatory bowel disease.
  • Current treatment by sacral nerve neurostimulation.
  • Cardiac pacemaker
  • Skin damages preventing transcutaneous electrical nerve stimulation (TENS).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
standard medical treatmentStandard medical treatmentstandard medical treatment
standard medical treatment + anoperineal physiotherapystandard medical treatment + anoperineal physiotherapy.standard medical treatment + anoperineal physiotherapy
Primary Outcome Measures
NameTimeMethod
The primary outcome variable is the patient's response to the question "How would you grade your symptom": major aggravation; aggravation, no changes, improvement and major improvement and rating of that change on an ordinal scale of -5 to +5. The pduring the treatment period
Secondary Outcome Measures
NameTimeMethod
Secondary outcomes include patient's symptoms questionnaire, continence score, quality of life questionnaire, stool diary and psychological status. These secondary outcomes are measured at the end of the 4 months treatment period and the end of follow-upat the end of the 4 months treatment period and the end of follow-up

Trial Locations

Locations (1)

Anne-Marie SCHOTT

🇫🇷

Lyon, France

© Copyright 2025. All Rights Reserved by MedPath